Seal

Market position

Seal positions itself against paper, spreadsheets and legacy GxP software stacks (MES, eQMS, LIMS, ELN and document tools) by unifying execution, records, validation, training and change control in one system. The website claims use by more than 50 GxP-regulated companies.

Seal emphasises: a single connected record spanning raw material to release; AI-drafted process builds and change proposals that always require human/QA approval; the ability to change validated processes through one governed change set that carries revalidation and retraining rather than a separate revalidation project; and rapid deployment of a first process within 48 hours, with additional processes added as configured blueprints rather than as new systems.

Technology

The platform combines a "GxP runtime" that executes procedures with in-line checks, spec enforcement, identity gating, e-signatures and QA gates, and a connected ontology (described as nine entity types and ten relations) linking inputs, run records and proof — for example patient, apheresis, vector, operator, instrument, potency result, deviation and release records for a CAR-T run. The AI layer, neil, converts source procedure documents into structured steps, checks and gates, connects run records and deviations to draft governed changes, and versions live processes so that revalidation checks, training gating and approvals are carried with each change while in-flight runs finish on the prior version.

Go-to-market

Seal promotes a rapid onboarding motion: a first process live in 48 hours, starting from a customer's own procedure (or a Seal sample) under NDA, with neil proposing the build in roughly 2.5 hours, customer review and e-signature, then training and go-live at T+48:00. Marketing centres on quantified customer case studies and testimonials from quality and engineering leaders. The company hires forward-deployed engineers and solutions consultants in London, San Francisco and Durham/NC, alongside BDR roles, indicating a direct, high-touch sales and deployment model.

GxP-regulated life-science and manufacturing organisations, including cell and gene therapy (CAR-T) producers, biomanufacturing and process development firms, antibody and allograft producers, medical-device/BCI developers and pre-clinical companies, plus some food and beverage quality operations. Named customers and reference users include Paradromics, Skye Biologics, Acclinate, Bioventix, MiAlgae, Ingenza, IMU Biosciences, OGI Bio, Revyve, Nordic Microbes, Nexterra Wine and Quality Wellness. Bioventix's quality manager characterises Seal as fitting companies that are neither enterprise scale nor startups.

Geography

Headquartered in London, United Kingdom per Y Combinator. Open roles are listed in London and elsewhere in England, plus San Francisco, California and Durham/North Carolina in the United States. Named customers are based in the UK, the US and continental Europe.

History

Y Combinator lists Seal as founded in 2019 and part of the Summer 2020 batch, with Harj Taggar as primary partner. Customer impact case studies published on Seal's site are dated between January 2025 and September 2025 (MiAlgae, Skye Biologics, Acclinate, Bioventix and a brain-computer-interface operations case study).

Risks & controversies

No controversies are reported in the available sources. Reported customer metrics are self-published by Seal and not independently verified. Several similarly named but unrelated companies exist (notably Seal Security, an application-security firm in Wilmington, Delaware, and the Run Seal Beach road race), creating identification risk in data collection.